Tags: Drug.

Losigamone is an investigational drug for the treatment of epilepsy. It has been studied as an add-on treatment for partial seizures. Phase III clinical trials were conducted around the year 2000.

Losigamone_skeletal.svg
ATC prefix
none
FDA UNII code
84R8O3QM2G
IUPAC name
(2R)-2-[(S)-(2-chlorophenyl)-hydroxymethyl]-3-methoxy-2H-furan-5-one
PubChem
6918049

Loading...

This page contains content from the copyrighted Wikipedia article "Losigamone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.